Effect of 17-alpha-hydroxyprogesterone 17-n-caproate on urine flow.
D000077713:17 alpha-Hydroxyprogesterone Caproate; D000328:Adult; D000368:Aged; D004965:Estrogen Antagonists / Q000627:therapeutic use; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D045167:Progesterone Congeners / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy*; D014555:Urination Disorders / Q000209:etiology / Q000503:physiopathology*; D014563:Urodynamics
D004965:Estrogen Antagonists; D006908:Hydroxyprogesterones; D045167:Progesterone Congeners; D000077713:17 alpha-Hydroxyprogesterone Caproate